Effect of Multiple Medicines on Dementia Initial Treatment: Experience and Thinking.
Jinghuan GanShuai LiuZhichao ChenXiao-Dan WangYong JiPublished in: American journal of Alzheimer's disease and other dementias (2022)
Little is known about multiple medicines and initial therapy among people with dementia. To examine the effect of multiple medicines on the initiation of anti-dementia therapy in patients diagnosed with cognitive impairment (CI), a retrospective study with 2742 CI patients was conducted based on the outpatients' medical records. The dementias receiving 1-2 drugs were more likely to be prescribed with anti-dementia (one drug: OR = 1.877; two drugs: OR = 1.770) and psychotropic (one drug: OR = 1.980) treatment, whereas had lower chances of receiving psychotropic medication with the combinations of more than three drugs (Alzheimer's disease: OR = .365; vascular dementia: OR = .940; frontotemporal lobe degeneration: OR = .957; and dementia with Lewy bodies/Parkinson's disease dementia: OR = .952). Multiple medicines can affect anti-dementia therapy initiation in dementia patients and should be paid extreme caution.
Keyphrases
- cognitive impairment
- mild cognitive impairment
- cognitive decline
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- healthcare
- emergency department
- prognostic factors
- stem cells
- peritoneal dialysis
- drug induced
- mesenchymal stem cells
- adverse drug
- combination therapy
- parkinson disease
- bone marrow
- replacement therapy
- amyotrophic lateral sclerosis